 The study found that supplementation of two glycerol esters, monobuturin, MB, and tributyrin, TB, could reduce inflammatory markers in the liver and intestine of rats fed a high-fat diet. This was achieved through changes in the gut microbiome, which resulted in lower levels of certain bacteria and higher levels of other bacteria. Additionally, these esters had beneficial effects on lipid metabolism, reducing cholesterol and triglyceride levels. This article was authored by Tao Duwei Nian, Alina Prichodko, Frida Fracolinius, and others.